AG
PTLA

Aperio Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Aperio Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
2020
Q2 		$781K Buy
2020
Q1 		$283K Buy
2019
Q4 		– Sell
2019
Q3 		$227K Buy
2019
Q2 		$152K Buy
2018
Q1 		– Sell
2017
Q4 		$232K Buy
2017
Q3 		$238K Sell
2017
Q2 		$250K Buy